ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 358

Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis

M. Elaine Husni1,2, Anthony Fernandez1, Rakesh Singh3, Brett Hauber4, Jessie Sutphin4, Joshua Posner4 and Arijit Ganguli3, 1Cleveland Clinic, Cleveland, OH, 2Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, 3AbbVie Inc., North Chicago, IL, 4RTI Health Solutions, Research Triangle Park, NC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Communication, patient outcomes, patient preferences, psoriatic arthritis and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Psoriasis and psoriatic arthritis arise from the same immune system response but result in different symptoms and impacts on daily activities. A patient with both conditions may be treated by a dermatologist, rheumatologist, or both. Our objective was to assess patient, dermatologist, and rheumatologist perceptions of the bother of individual psoriatic outcomes in 3 separate areas: skin and joint symptoms and impacts on daily activities.

Methods: We developed a set of 7 skin symptoms, 7 joint symptoms, and 6 impacts on daily activities of psoriatic disease from existing validated measures. To measure perceived relative bother, we created an online best-worst scaling survey in which patients, dermatologists, and rheumatologists in the US, recruited through internet panels, indicated which of 5 items from the full set of 20 was most and least bothersome in each of 16 questions determined by an experimental design. We used these data to rank perceived relative bother in skin symptoms, joint symptoms, and daily activities for each respondent group.

Results: We surveyed 200 patients with self-reported physician diagnosis of both psoriasis and psoriatic arthritis with mean (SD) age of 42 (14) years. On a scale from 0 (none) to 10 (severe), patients had mean self-reported skin symptoms of 6.8 (2.5) and joint symptoms of 6.4 (2.6). Patients, dermatologists (n=150), and rheumatologists (n=150) differed on the most bothersome skin symptom (Table 1). All respondent groups ranked joint pain, soreness, or tenderness as the most bothersome joint symptom and discomfort while doing everyday tasks as the most bothersome impact on daily activities. Among skin symptoms, embarrassment was ranked highest (most bothersome) by dermatologists, while painful skin was ranked higher than embarrassment by patients and rheumatologists. Among joint symptoms, patients and physicians ranked the relative burden of eye problems differently. Among daily activities, patients and physicians ranked the relative bother of difficulty sleeping differently.

Conclusion: The perception of the bother of psoriatic disease outcomes differs among patients, dermatologists, and rheumatologists. Greater communication among these groups is warranted and may help patients and physicians better address patient needs.

 

 

 


Disclosure: M. E. Husni, AbbVie, Genentech, Bristol-Myers Squibb, Pfizer, Novartis, and Janssen, 9; A. Fernandez, Mallinkrodt, Roche, AbbVie, 2,AbbVie, 5,Celgene, AbbVie, 8; R. Singh, AbbVie, 3,AbbVie, 1; B. Hauber, RTI, which has received consulting fee from AbbVie to partner on this research, 3; J. Sutphin, RTI, which has received consulting fee from AbbVie to partner on this research, 3; J. Posner, RTI, which has received consulting fee from AbbVie to partner on this research, 3; A. Ganguli, AbbVie, 3,AbbVie, 1.

To cite this abstract in AMA style:

Husni ME, Fernandez A, Singh R, Hauber B, Sutphin J, Posner J, Ganguli A. Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/patients-and-physicians-have-different-perceptions-of-the-relative-bother-of-the-symptoms-and-impacts-on-daily-activities-in-psoriasis-and-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-and-physicians-have-different-perceptions-of-the-relative-bother-of-the-symptoms-and-impacts-on-daily-activities-in-psoriasis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology